CoChat

Clinical Predictors of Drug Response in Obsessive-Compulsive Disorder

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

The aim of this study was to evaluate which clinical variables might influence the antiobsessional response to proserotonergic drugs in a sample of patients with obsessive-compulsive disorder (OCD). One hundred fifty-nine patients with DSM-IV OCD underwent a 12-week standardized treatment with fluvoxamine, clomipramine, citalopram, or paroxetine. According to treatment response, defined as a reduction of the Yale-Brown Obsessive Compulsive Scale total score >35%, patients were divided into two groups. Ninety patients (56.6%) responded to treatment and 69 (43.4%) did not. Responders had a significantly higher frequency of positive family history for OCD (FH-OCD) in their first-degree relatives, whereas nonresponders had an earlier onset and a higher frequency of "poor insight" subtype and somatic obsessions. The predictive value of all these variables was tested by a stepwise logistic regression analysis that confirmed poor insight and FH-OCD to be the best predictors of poor and good drug treatment response, respectively. These preliminary findings need additional investigations toward a better definition of the genetic and biological heterogeneity of patients with OCD, and they underlie the importance of collecting the insight score and family history for psychiatric disorders in the pretreatment assessment.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004714-200110000-00006

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 8

  1. Smeraldi, 1992, New Trends Exp Clin Psychiatry, 8, 63
  2. Ravizza, 1995, J Clin Psychiatry, 56, 368
  3. Ackerman, 1996, Psychopharmacol Bull, 32, 157
  4. Carrasco, 1992, J Clin Psychiatry, 53, 387
  5. Rasmussen, 1990, J Clin Psychiatry, 51suppl, 10
  6. Foa, 1995, Am J Psychiatry, 1, 90
  7. Phillips, 1998, Bull Menninger Clin, 62, A33
  8. Pauls, 1995, Am J Psychiatry, 159, 76

Cited by

See all 224

Metadata

Authors
Erzegovesi, S., Cavallini, M. C., Cavedini, P., Diaferia, G., Locatelli, M., & Bellodi, L.
Affiliations
University of Milan (IT)
Venue
Journal of Clinical Psychopharmacology
Published
2001-10
Volume
21
Issue
5
Pages
488-492
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2334177155
Cited by
224
References
31
Citations by year
2026: 4 · 2025: 2 · 2024: 6 · 2023: 3 · 2022: 7 · 2021: 13 · 2020: 7 · 2019: 8 · 2018: 10 · 2017: 5 · 2016: 7 · 2015: 12 · 2014: 12 · 2013: 14 · 2012: 11
FWCI
9.77
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords
obsessive-compulsive disorder, treatment response prediction, fluvoxamine, clomipramine, citalopram, paroxetine, insight, age of onset, genetic heterogeneity, Yale-Brown Obsessive Compulsive Scale
MeSH terms
Adolescent, Adult, Aged, Analysis of Variance, Clomipramine, Drug Resistance, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder, Predictive Value of Tests, Psychological Tests, Random Allocation, Regression Analysis, Citalopram, Fluvoxamine, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Paroxetine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Predictors of Drug Response in Obsessive-Compulsive Disorder. https://app.cochat.ai/papers/10.1097/00004714-200110000-00006
The paper
Erzegovesi, S., Cavallini, M. C., Cavedini, P., Diaferia, G., Locatelli, M., & Bellodi, L. (2001). Clinical Predictors of Drug Response in Obsessive-Compulsive Disorder. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-200110000-00006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.